Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Enhancing Continuity with Online Meetings – Perks of Virtual Medical Education

August 8, 2024 | CME, Continuing medical education, Healthcare tech, Impetus Digital, Online Learning, Perks of digital, Pharma tips, Pharma trends, med ed, medical education, online CME, virtual CM E, virtual education, virtual learning 

Explore the power of online meetings for superior continuity in our latest video from the “Perks of Virtual Medical Education” series. Learn how shorter, more frequent virtual touchpoints allow for enhanced storytelling, more digestible information, and stronger participant relationships over time.

Dive into the advantages of online meetings for maintaining continuity in our fifth video from the “Perks of Virtual Medical Education” series. Discover how frequent virtual touchpoints can enhance storytelling and relationship building.

5. Online Meetings Allow for Superior Continuity Online meetings redefine how organizers connect and engage with participants, providing a platform for more consistent and frequent interactions compared to traditional annual meetings. This approach allows for the development of authentic relationships over time, building a compelling narrative across multiple sessions. Moreover, the shorter and more regular virtual touchpoints ensure that information is delivered in digestible pieces, which not only facilitates better understanding but also allows for deeper processing by participants. The result is more detailed and thoughtful responses, contributing to a more effective and meaningful engagement.

Explore the benefits of continuous virtual interaction and how it can transform your medical education and collaboration efforts on our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your virtual engagements with Impetus Digital:

Stay connected for more insights and updates:

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...